Provides clinical solutions to hospitals and healthcare organizations. Offers AI-powered software suites for tax and accounting firms. Now — the numbers.
This is an established company with proven profits.
Average growth of 6% a year over the last 4 years. Every year shown ended in profit.
The gap is $4.9B. In times of high interest rates, a gap like that can squeeze a company.
The market pays 11.6× for every dollar of annual profit — cheap, which is either an opportunity or a warning.
No analyst target is on record for this company.
The stock trades 59% below its peak. The market has trimmed its expectations for the company.
The net profit margin is 21% — still a thick cushion, though costs have been eating into it lately.
It pays out $3.02 per share each year — regular cash for whoever holds the stock.
Since the drop from its peak, buyer appetite hasn’t come back.
Against everything we grade, WOLTF lands somewhere in the middle. The grade moves as the numbers move.
The takeaway: WOLTF is an established business that has proven its profits for years. The real debate isn’t the quality of the business — it’s whether the price paid for the stock is too high.
Not covered, because the filings we hold do not carry it: the revenue breakdown.